About Me

header ads

LANXESS exhibits consumer protection portfolio at In-cosmetics Asia in Thailand

  • LANXESS at in-cosmetics Asia, November 1-3, 2022, BITEC, Bangkok, Thailand, Booth K50A+B


Bangkok, November 4 2022 – German specialty chemicals company LANXESS is showcasing from November 1 to 3 at in-cosmetics Asia in Bangkok its comprehensive portfolio and concentrated expertise in the field of active ingredients and formulations for personal care products. 


Sustainable preservation of green and clean label products


The LANXESS Flavors & Fragrances (F&F) business unit is presenting its comprehensive portfolio for personal care, including preservatives, multifunctionals and emollients.


Benzoic acid (Purox B) and sodium benzoate (Purox S) are very effective nature-identical and fully biodegradable preservatives. They protect personal care products effectively against bacteria and especially against fungi. The antimicrobial activity of Purox can be enhanced by the multifunctional Kalama 3PP, which is also nature-identical. This allows the use of Purox at higher pH values.


"Green" surfactants: Added value for consumers and the environment


The green multifunctional Solbrol CLL is ideal for body care products in the clean label area. This active ingredient creates a long-lasting foam with small pore sizes. Therefore the foam is perceived as particularly mild and caring by consumers. In addition, Solbrol CLL has antimicrobial properties and can be used as an active in anti-dandruff and anti-acne formulations. Solbrol CLL is based on coconut oil and is 100% renewable. "Green surfactants like CLL play an important role in the development of end products with an optimized environmental and safety profile," explains Dr. Matthias Kunze, Business Development Manager in the Flavors & Fragrances division.


Healthcare by Saltigo – long-lasting, yet gentle protection against insect bites


The wholly-owned LANXESS subsidiary Saltigo is presenting the insect repellent Saltidin®, which is ideal not only for producers of insect repellents but also of cosmetics, who are looking to supplement their product portfolio with a gentle and effective health care product. “Products containing Saltidin® provide long-lasting protection against insects and ticks that may transmit the pathogens that cause diseases such as dengue fever, malaria, Lyme disease, among others. It is also highly effective, yet gentle and suitable for use in a wide range of cosmetic formulations – a quite remarkable combination,” Dr. Nora Hofmann, Global Business Manager Saltidin® at Saltigo GmbH, said. 


The active ingredient is an alternative to DEET and is marketed under the brand name Saltidin®. Also known as Icaridin or Picaridin, it has been recommended by numerous national and international health organizations as an effective prophylaxis. Thanks to its outstanding cosmetic characteristics and effectivity, it can be used for the production of insect repellent applications for the whole family.


LANXESS launches new Care business line 


LANXESS is also presenting its new Care business line, which was established following the acquisition of the microbial control business from U.S. Corporation International Flavors & Fragrances and further strengthens the company’s consumer protection segment. This business line is integrated in LANXESS’s Material Protection Products (MPP) business unit, which specializes in microbial applications. 






About LANXESS

LANXESS is a leading specialty chemicals company with sales of EUR 6.1 billion in 2020. The company currently has about 14,300 employees in 33 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.


LANXESS China

On January 31, 2005, the company was initially listed on the Frankfurt Stock Exchange and LANXESS Chemical (China) Co., Ltd. officially started operations. LANXESS now has 15 subsidiaries, 7 R&D centers and 8 production sites with around 1,500 employees in Greater China. LANXESS works closely with its local partners to develop market-oriented solutions that meet local market needs.


Forward-Looking Statements

This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development, or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.


Information for editors:

All LANXESS news releases and accompanying photo, video and audio materials can be found at http://www.lanxess.cn, http://www.weibo.com/lanxess, or LANXESS’ official WeChat account:
lanxess_china (QR code provided below)












Follow us on Twitter, Facebook, LinkedIn and YouTube:


http://www.twitter.com/LANXESS

http://www.facebook.com/LANXESS

http://www.linkedin.com/company/lanxess

http://www.youtube.com/lanxess